Compartir
Título
Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study
Autor(es)
Materia
Switching strategy
Prsexdq-salsex questionnaire
Treatment
Antidepressant
Sexual dysfunction
Desvenlafaxine
Clasificación UNESCO
3211 Psiquiatría
Fecha de publicación
2019
Editor
Journal of Clinical Medicine
Citación
Montejo, A. L., Becker, J., Bueno, G., Fernández-Ovejero, R., Gallego, M. T., González, N., Juanes, A., Montejo, L., Pérez-Urdániz, A., Prieto, N., & Villegas, J. L. (2019). Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study. Journal of Clinical Medicine, 8(5), 719. https://doi.org/10.3390/jcm8050719
Resumen
[EN] Despite being clinically underestimated, sexual dysfunction (SD) is one of the most frequent and lasting adverse effects associated with antidepressants. Desvenlafaxine is an antidepressant (AD) with noradrenergic and serotonergic action that can cause a lower SD than other serotonergic ADs although there are still few studies on this subject. Objective: To check the frequency of SD in two groups of depressive patients: one group was desvenlafaxine-naïve; the other was made up of patients switched to desvenlafaxine from another AD due to iatrogenic sexual dysfunction. A naturalistic, multicenter, and prospective study of patients receiving desvenlafaxine (50–100 mg/day) was carried out on 72 patients who met the inclusion criteria (>18 years old and sexually active), who had received desvenlafaxine for the first time (n = 27) or had switched to desvenlafaxine due to SD with another AD (n = 45).
URI
DOI
10.3390/jcm8050719
Versión del editor
Colecciones
Ficheros en el ítem
Tamaño:
2.608Mb
Formato:
Adobe PDF